960 related articles for article (PubMed ID: 17353377)
1. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
[TBL] [Abstract][Full Text] [Related]
2. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
3. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.
Fukumoto H; Tennis M; Locascio JJ; Hyman BT; Growdon JH; Irizarry MC
Arch Neurol; 2003 Jul; 60(7):958-64. PubMed ID: 12873852
[TBL] [Abstract][Full Text] [Related]
4. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
Gurol ME; Irizarry MC; Smith EE; Raju S; Diaz-Arrastia R; Bottiglieri T; Rosand J; Growdon JH; Greenberg SM
Neurology; 2006 Jan; 66(1):23-9. PubMed ID: 16401840
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
[TBL] [Abstract][Full Text] [Related]
6. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
Geda YE; Knopman DS; Mrazek DA; Jicha GA; Smith GE; Negash S; Boeve BF; Ivnik RJ; Petersen RC; Pankratz VS; Rocca WA
Arch Neurol; 2006 Mar; 63(3):435-40. PubMed ID: 16533972
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
8. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
Fagan AM; Roe CM; Xiong C; Mintun MA; Morris JC; Holtzman DM
Arch Neurol; 2007 Mar; 64(3):343-9. PubMed ID: 17210801
[TBL] [Abstract][Full Text] [Related]
10. Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.
Blasko I; Jungwirth S; Jellinger K; Kemmler G; Krampla W; Weissgram S; Wichart I; Tragl KH; Hinterhuber H; Fischer P
J Psychiatr Res; 2008 Sep; 42(11):946-55. PubMed ID: 18155247
[TBL] [Abstract][Full Text] [Related]
11. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
[TBL] [Abstract][Full Text] [Related]
12. Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly.
Qiu WQ; Sun X; Selkoe DJ; Mwamburi DM; Huang T; Bhadela R; Bergethon P; Scott TM; Summergrad P; Wang L; Rosenberg I; Folstein M
Int J Geriatr Psychiatry; 2007 Jun; 22(6):536-42. PubMed ID: 17096467
[TBL] [Abstract][Full Text] [Related]
13. Plasma Abeta levels do not reflect brain Abeta levels.
Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid beta protein in young and elderly depression: a pilot study.
Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
[TBL] [Abstract][Full Text] [Related]
16. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment.
Jessen F; Wiese B; Bachmann C; Eifflaender-Gorfer S; Haller F; Kölsch H; Luck T; Mösch E; van den Bussche H; Wagner M; Wollny A; Zimmermann T; Pentzek M; Riedel-Heller SG; Romberg HP; Weyerer S; Kaduszkiewicz H; Maier W; Bickel H;
Arch Gen Psychiatry; 2010 Apr; 67(4):414-22. PubMed ID: 20368517
[TBL] [Abstract][Full Text] [Related]
17. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.
Li G; Sokal I; Quinn JF; Leverenz JB; Brodey M; Schellenberg GD; Kaye JA; Raskind MA; Zhang J; Peskind ER; Montine TJ
Neurology; 2007 Aug; 69(7):631-9. PubMed ID: 17698783
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
[TBL] [Abstract][Full Text] [Related]
19. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
20. Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
Stomrud E; Hansson O; Zetterberg H; Blennow K; Minthon L; Londos E
Arch Neurol; 2010 Feb; 67(2):217-23. PubMed ID: 20142530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
